Oncolytics Biotech (ONCY) Reports Q2 Loss of $0.03/Share

Oncolytics Biotech (NASDAQ: ONCY) reported Q2 EPS of ($0.03), versus ($0.05) reported last year.

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• ThinkEquity Starts Deep Isolation Nuclear (DBHL) at Buy
• S&P 500 eyes record as retail slump, Iran risk set up pivotal week